Update
$Fractyl Health (GUTS.US)$ Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024. VIA GLOBENEWSWIRE Results showed single-administration GLP-1 pancreatic gene therapy candidate reduced liver weight by 42%
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment